Collection: Herpes Simplex Virus Type 1 (HSV-1)
Herpes Simplex Virus Type 1 (HSV-1) is a common pathogen responsible for oral and ocular infections. A crucial component of HSV-1's ability to infect host cells is its glycoprotein, particularly glycoprotein D (gD), which binds to cellular receptors to facilitate viral entry. Glycoprotein D interacts with specific receptors on the surface of host cells, such as herpesvirus entry mediator (HVEM), nectin-1, and 3-O-sulfated heparan sulfate. Understanding this receptor-ligand interaction is vital for developing targeted antiviral therapies and vaccines. In recent research, HSV-1 glycopeptides have been explored for their potential in diagnostic assays and as candidates for vaccine development. Additionally, these glycopeptides serve as models for studying viral entry mechanisms and host-pathogen interactions.
-
GPAT*PAP-NH2
where T* = Thr* = Thr(Sialyl Tn) = Thr(STn) = Neu5Acα2-6GalNAcα-O-ThrIn Stock -
Biotin-GPAT*PAP-NH2
where T* = Thr* = GalNAcα-O-ThrInquire -
-
Biotin-GPAT*PAP-NH2
where T* = Thr* = Thr(Sialyl Tn) = Thr(STn) = Neu5Acα2-6GalNAcα-O-ThrIn Stock -
T*PAPP-NH2
where T* = Thr* = Thr(Sialyl Tn) = Thr(STn) = Neu5Acα2-6GalNAcα-O-ThrInquire -
T*PAP-NH2
where T* = Thr*= Thr(Sialyl Tn) = Thr(STn) = Neu5Acα2-6GalNAcα-O-ThrInquire
Interested in Custom Synthesis?
Require a personalized glycopeptide or peptide sequence, or specific modifications? Explore our tailored synthesis services, precisely designed to meet your unique requirements.